Pharma AI glossary
Article 4 (EU AI Act)
The AI-literacy obligation: providers and deployers "shall take measures to ensure, to their best extent, a sufficient level of AI literacy of their staff and other persons dealing with the operation and use of AI systems on their behalf," proportionate to technical knowledge, experience, education, and context of use.
Definition
The AI-literacy obligation: providers and deployers "shall take measures to ensure, to their best extent, a sufficient level of AI literacy of their staff and other persons dealing with the operation and use of AI systems on their behalf," proportionate to technical knowledge, experience, education, and context of use. Applicable since February 2, 2025; national enforcement powers since August 2, 2026. No direct EU-level fine attaches to Article 4 alone; its teeth are indirect: aggravating factor in other AI Act enforcement, evidence in negligence claims, and inspection findings. The compliance standard is due diligence demonstrated by contemporaneous records: who was trained, on what, matched to what role and risk.
The literacy obligation
Article 4 requires providers and deployers to ensure sufficient AI literacy for staff and others operating AI on their behalf, proportionate to technical knowledge, experience, education, and context of use. Applicable since February 2025; national enforcement powers strengthen from August 2026.
Pharma evidence
No standalone EU fine attaches only to Article 4, but it can factor into broader enforcement and inspection narratives. Demonstrate due diligence with contemporaneous records: who was trained, on what, mapped to role and system risk. The Literacy Center’s ~54-minute curriculum and assessment are one structured option, not legal advice.
Frequently asked questions
Does Article 4 apply to US-only manufacturers?
It applies to deployers placing AI on the EU market or affecting EU patients/products. Footprint matters, not headquarters zip code.
What counts as sufficient literacy?
Proportionate competence to use and oversee AI safely for that role, whether on the line, in QA, validation, or document control. Benchmarks, modules, and documented assessment help; tick-box videos alone do not.
Does Article 4 cover manufacturing and QA equally?
It covers anyone operating or overseeing AI on the deployer’s behalf, mapped to context of use. A vision-system operator, a batch-record reviewer using RAG, and an IT owner qualifying an agent harness all need literacy scaled to their decision consequence.
Related terms
Benchmark your AI literacy
Free 20-question assessment, eight modules, and instant scoring, built for pharma quality and manufacturing teams.
Open the Literacy CenterBrowse all terms
See the full 71-term glossary index or search interactively in the Literacy Center.
Back to glossary hub →Educational content only, not legal or regulatory advice. Regulatory guidance cited here includes drafts (FDA AI credibility guidance; EU GMP Annex 22) as of August 2026; verify against final texts before relying on them in submissions. Company-reported figures (Merck CSR timings, Sanofi results) are labeled where used. MIT's ~95% pilot figure carries its own caveat (~150 interviews, contested definitions, not peer-reviewed). Re-check sources on module finalization.